Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New antidepressants with improved safety reported by BMS

Nov. 15, 1996

Dutch researcher reports potential CNS agents

Nov. 15, 1996

Antipsychotic agents from Taisho

Nov. 15, 1996

New light shed on an old drug: Morphine and its mechanism of action

Nov. 15, 1996

Fujisawa transfers rights to analgesic product to Roxane

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

New NK1 antagonists claimed by Takeda

Nov. 15, 1996

Cortech announces further delays in development of Bradycor

Nov. 8, 1996

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Mitsubishi reports cathepsin B/calpain inhibitors

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...